Clinical trial
Alfuzosin for Treating Acute Urinary Retention
NCT00336921 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00336921 |
|---|---|
| Title | Alfuzosin for Treating Acute Urinary Retention |
| Official title | A Double-blind, Randomized,Placebo Controlled Study of Alfuzosin 10mg od in the Return to Successful Voiding in Patients With a First Episode of Acute Urinary Retention Due to Benign Prostatic Hyperplasia |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Urinary Retention |
| Intervention type | Drug |
| Interventions | Alfuzosin, Placebo |
| Enrollment | 156 |
| Start date | Feb 1, 2006 |
| Primary completion | Apr 1, 2007 |
| First posted | Jun 15, 2006 |
| Last update posted | Sep 15, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: